Xvivo Perfusion AB (publ) (0RKL.L)
SEK 461.69
(1.25%)
SEK 461.69
(1.25%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.19 Billion SEK | 26.69% |
| 2022 | 1.73 Billion SEK | 12.35% |
| 2021 | 1.54 Billion SEK | 34.1% |
| 2020 | 1.15 Billion SEK | 81.3% |
| 2019 | 634.48 Million SEK | 8.16% |
| 2018 | 586.61 Million SEK | 8.93% |
| 2017 | 538.54 Million SEK | 54.18% |
| 2016 | 349.29 Million SEK | 71.07% |
| 2015 | 204.18 Million SEK | 1.23% |
| 2014 | 201.7 Million SEK | 58.12% |
| 2013 | 127.56 Million SEK | 11.39% |
| 2012 | 114.51 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 2.27 Billion SEK | 0.23% |
| 2024 Q1 | 2.25 Billion SEK | 2.65% |
| 2024 Q2 | 2.27 Billion SEK | 0.86% |
| 2023 Q2 | 1.78 Billion SEK | 2.79% |
| 2023 Q3 | 2.23 Billion SEK | 25.09% |
| 2023 Q4 | 2.19 Billion SEK | -1.85% |
| 2023 FY | 2.19 Billion SEK | 26.69% |
| 2023 Q1 | 1.73 Billion SEK | 0.39% |
| 2022 Q3 | 1.64 Billion SEK | 3.57% |
| 2022 Q4 | 1.73 Billion SEK | 5.58% |
| 2022 Q1 | 1.52 Billion SEK | -1.17% |
| 2022 FY | 1.73 Billion SEK | 12.35% |
| 2022 Q2 | 1.58 Billion SEK | 3.95% |
| 2021 Q2 | 1.14 Billion SEK | -1.61% |
| 2021 Q4 | 1.54 Billion SEK | 34.8% |
| 2021 Q1 | 1.16 Billion SEK | 1.55% |
| 2021 FY | 1.54 Billion SEK | 34.1% |
| 2021 Q3 | 1.14 Billion SEK | -0.43% |
| 2020 Q3 | 1.11 Billion SEK | 80.38% |
| 2020 Q4 | 1.15 Billion SEK | 2.79% |
| 2020 FY | 1.15 Billion SEK | 81.3% |
| 2020 Q2 | 620.4 Million SEK | -3.76% |
| 2020 Q1 | 644.66 Million SEK | 1.6% |
| 2019 Q4 | 634.48 Million SEK | -3.46% |
| 2019 FY | 634.48 Million SEK | 8.16% |
| 2019 Q1 | 601.19 Million SEK | 2.49% |
| 2019 Q3 | 657.22 Million SEK | 1.98% |
| 2019 Q2 | 644.45 Million SEK | 7.19% |
| 2018 Q2 | 576.64 Million SEK | 6.42% |
| 2018 Q1 | 541.86 Million SEK | 0.62% |
| 2018 FY | 586.61 Million SEK | 8.93% |
| 2018 Q4 | 586.61 Million SEK | 1.36% |
| 2018 Q3 | 578.74 Million SEK | 0.36% |
| 2017 Q3 | 528.37 Million SEK | -0.29% |
| 2017 Q2 | 529.91 Million SEK | 55.44% |
| 2017 Q4 | 538.54 Million SEK | 1.92% |
| 2017 Q1 | 340.91 Million SEK | -2.4% |
| 2017 FY | 538.54 Million SEK | 54.18% |
| 2016 Q4 | 349.29 Million SEK | 0.72% |
| 2016 Q3 | 346.8 Million SEK | 1.72% |
| 2016 Q2 | 340.92 Million SEK | 65.54% |
| 2016 FY | 349.29 Million SEK | 71.07% |
| 2016 Q1 | 205.94 Million SEK | 0.86% |
| 2015 Q1 | 202.29 Million SEK | 0.29% |
| 2015 Q4 | 204.18 Million SEK | 1.51% |
| 2015 Q3 | 201.15 Million SEK | -0.83% |
| 2015 Q2 | 202.84 Million SEK | 0.27% |
| 2015 FY | 204.18 Million SEK | 1.23% |
| 2014 Q4 | 201.7 Million SEK | 3.34% |
| 2014 FY | 201.7 Million SEK | 58.12% |
| 2014 Q2 | 209.16 Million SEK | 59.16% |
| 2014 Q1 | 131.41 Million SEK | 3.02% |
| 2014 Q3 | 195.17 Million SEK | -6.69% |
| 2013 Q2 | 113.03 Million SEK | 3.8% |
| 2013 Q4 | 127.56 Million SEK | 8.18% |
| 2013 Q3 | 117.91 Million SEK | 4.32% |
| 2013 FY | 127.56 Million SEK | 11.39% |
| 2013 Q1 | 108.89 Million SEK | -4.91% |
| 2012 Q4 | 114.51 Million SEK | 0.0% |
| 2012 FY | 114.51 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|